This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
